ARCHIVES

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

This article is from The Cancer Letter archive.

Vol. 30 No. 42 | November 5, 2004

Download PDF Visit The Full Archive

Related Articles

ACCC Statement, ASCO Comments On Health Reform

March 26, 1993

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

NCI Disappointed Over Response To Survey Leads; CRAG Proposals Inadequate, More Will Be Sought

August 6, 1976

In Brief: Broder Wins ARC’s Griffuel Prize; Lawyers Trained To Help Low-Income Breast Ca, Patients

October 16, 1992

CDC: About 8 Million Women Skipped Cervical Cancer Screening in the Past 5 Years

November 14, 2014

Court Order May Clear Way From Big Landow-Blair-Switch

July 6, 1984